Literature DB >> 10928977

Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.

X P Yang1, S Chiba.   

Abstract

The periarterial electrical nerve stimulation (30 s trains of pulses at a frequency of 1, 4 or 10 Hz) induced a double peaked vasoconstriction consisting of an initial transient constriction (first peak) followed by a prolonged response (second peak) in the isolated, perfused canine splenic artery. At low frequencies (1 and 4 Hz), a neuropeptide Y (NPY) Y(1) receptor antagonist BIBP 3226 (0.1-1 microM) produced a dose-dependent inhibitory effect on the second peak, but did not modify the first peak. At a high frequency (10 Hz), 1 microM BIBP 3226 induced a slight, but significant inhibition on both the first and second peaked responses. At a low frequency (1 Hz), the first peak was not influenced by blockade of alpha(1)-adrenoceptors or NPY Y(1) receptors with prazosin (0.1 microM) or BIBP 3226 (1 microM), respectively, but abolished by P2X receptor desensitization with alpha,beta-methylene ATP (alphabeta-m ATP, 1 microM). At a high frequency (10 Hz), the first peak was mostly inhibited by alphabeta-m ATP and partially by prazosin and BIBP 3226. On the other hand, the second peak at a low frequency was largely decreased by BIBP 3226 and partially by prazosin and alphabeta-m ATP, whereas at a high frequency, it was largely attenuated by prazosin and partially by alphabeta-m ATP and BIBP 3226. The results suggest that at a low frequency, the firstly transient constriction of double peaked responses is mainly induced via an activation of P2X-receptors, whereas at a high frequency, it is mostly mediated by the P2X-receptors, and partially by alpha(1)-receptors and NPY Y(1)-receptors. The secondary prolonged vasoconstriction at frequencies used is predominantly mediated via both alpha(1)-receptor and NPY Y(1) receptor activations, and in part by P2X-receptors. Furthermore, an activation of NPY Y(1) receptors may play an important role in evoking the prolonged vasoconstrictor response to longer pulse trains of stimulation at a low frequency, whereas an alpha(1)-adrenoceptor activation exerts a main vasomotor effect for the prolonged response at a high frequency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928977      PMCID: PMC1572238          DOI: 10.1038/sj.bjp.0703484

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Neuropeptide Y-ATP interactions and release at the vascular neuroeffector junction.

Authors:  T C Westfall; C L Yang; D Rotto-Perceley; H Macarthur
Journal:  J Auton Pharmacol       Date:  1996-12

2.  Neuropeptide Y, enkephalin and noradrenaline coexist in sympathetic neurons innervating the bovine spleen. Biochemical and immunohistochemical evidence.

Authors:  G Fried; L Terenius; E Brodin; S Efendic; G Dockray; J Fahrenkrug; M Goldstein; T Hökfelt
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

3.  Neuropeptide Y-mediated pressor responses following high-frequency stimulation of the rat sympathetic nervous system.

Authors:  B Kennedy; G H Shen; M G Ziegler
Journal:  J Pharmacol Exp Ther       Date:  1997-04       Impact factor: 4.030

4.  Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport.

Authors:  J M Lundberg; A Rudehill; A Sollevi; G Fried; G Wallin
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

5.  The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226.

Authors:  K Rudolf; W Eberlein; W Engel; H A Wieland; K D Willim; M Entzeroth; W Wienen; A G Beck-Sickinger; H N Doods
Journal:  Eur J Pharmacol       Date:  1994-12-27       Impact factor: 4.432

6.  Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435.

Authors:  R E Malmstrom; J M Lundberg
Journal:  Eur J Pharmacol       Date:  1995-12-29       Impact factor: 4.432

7.  Adrenergic-purinergic interactions on vasoconstrictor responses to periarterial electric nerve stimulation in canine splenic arteries.

Authors:  X P Yang; S Chiba
Journal:  J Auton Pharmacol       Date:  1999-06

8.  SR 120107A antagonizes neuropeptide Y Y1 receptor mediated sympathetic vasoconstriction in pigs in vivo.

Authors:  R E Malmström; A Modin; J M Lundberg
Journal:  Eur J Pharmacol       Date:  1996-06-03       Impact factor: 4.432

9.  A new method for measuring vascular responsiveness of relatively larger arteries of dogs.

Authors:  K Hongo; S Chiba
Journal:  J Pharmacol Methods       Date:  1983-02

10.  Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.

Authors:  J M Lundberg; A Modin
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

View more
  3 in total

1.  Exhaustive swimming differentially inhibits P2X1 receptor- and α1-adrenoceptor-mediated vasoconstriction in isolated rat arteries.

Authors:  Lu Li; Tao Wu; Cong Wei; Jian-ke Han; Zhen-hua Jia; Yi-ling Wu; Lei-ming Ren
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

2.  Neurogenic double-peaked vasoconstriction of human gastroepiploic artery is mediated by both alpha1- and alpha2-adrenoceptors.

Authors:  Daisuke Fukui; Xiao-Ping Yang; Shigetoshi Chiba
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

3.  Existence of different alpha(1)-adrenoceptor subtypes in junctional and extrajunctional neurovascular regions in canine splenic arteries.

Authors:  X P Yang; S Chiba
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.